ESTRO 2024 - Abstract Book
S2846
Interdisciplinary - Health economics & health services research
ESTRO 2024
Keywords: value, categorisation, innovation
References:
1. Jabareen Y. Building a Conceptual Framework: Philosophy, Definitions, and Procedure. International Journal of Qualitative Methods. 2009;8(4):49-62.
2. Lievens Y, Grau C, Aggarwal A. Value-based health care - what does it mean for radiotherapy? Acta oncologica (Stockholm, Sweden). 2019;58(10):1328-32.
3. Lievens Y, Audisio R, Banks I, Collette L, Grau C, Oliver K, et al. Towards an evidence-informed value scale for surgical and radiation oncology: a multi-stakeholder perspective. Lancet Oncol. 2019;20(2):e112-e23.
4. Lievens Y, Borras JM, Grau C, Aggarwal A. Value-based radiotherapy: A new chapter of the ESTRO-HERO project. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2021;160:236-9. 5. Vandemaele M, Aznar M, Blanchard P, Borras JM, Leech M, Aggarwal A, Lievens Y. A systematic literature review of definitions and classification systems for radiotherapy innovation: A first step towards building a value-based assessment tool for radiation oncology. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2023;183:109602.
2503
Proffered Paper
Cost-consequence analysis of radiographer target volume online contouring for prostate MRIgRT
Emma Xue 1 , Bethany Williams 2 , Alison Tree 3 , Helen McNair 3 , Kyriaki Giorgakoudi 1,4
1 City, University of London, Department of Health Services Research and Management, London, United Kingdom. 2 Royal Marsden NHS Foundation Trust, Radiotherapy, London, United Kingdom. 3 The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Radiotherapy, London, United Kingdom. 4 NIHR Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Biomedical Research, London, United Kingdom
Purpose/Objective:
MRI guided radiotherapy (MRIgRT) using the Elekta Unity MR Linac (MRL) (Elekta AB, Stockholm, Sweden), has opened promising opportunity for hypofractionation, dose escalation and potential of reduced target volume margins in adaptive prostate radiotherapy. In conventional adaptive MRL workflows, the responsibility of online contouring of target volumes and OAR lies with the clinician, yet this approach poses challenges in terms of resource intensity. Alongside delegation of plan approval to physicists, a way to alleviate this is through a shift towards entrusting therapeutic radiographers (RTT) with the task of online target volume contouring.
Made with FlippingBook - Online Brochure Maker